PPM1D and medulloblastoma: Furthermore, genetic instability and accumulation of genetic aberrations over time are major obstacles in metastatic and relapsing pediatric cancers, further supporting the potential role and impact of WIP1 as a promising therapeutic target for pediatric patients with high-risk neuroblastoma and medulloblastoma, as well as a wide range of adult cancer patients.